Pharmabiz2d
DFE Pharma expands its C2F Center of Excellence in Hyderabad to advance the development of critical respiratory treatments
DFE Pharma, a global leader in pharmaceutical and biopharmaceutical excipient solutions, has expanded the capabilities of its Closer to the Formulator (C2F) Center of Excellence located in Genome ...
Pharmabiz2d
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples
Illumina launches pilot proteomics programme with UK Biobank and biopharma collaborators to analyze 50,000 samples: San Diego Tuesday, January 14, 2025, 13:00 Hrs [IST] Illumina, ...
Pharmabiz2d
Telix to buy next-generation therapeutic assets and innovative biologics technology platform from ImaginAb
Telix, a commercial-stage biopharmaceutical company, announces it has entered into an asset purchase agreement with antibody engineering company ImaginAb, Inc. (ImaginAb) to acquire a pipeline of next ...
Pharmabiz2d
Telix enters agreement with Curium Pharma for transfer of marketing and distribution rights for Scintimun
Telix, a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals, announces that it has entered ...
Pharmabiz7h
GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy
GenSight Biologics announces publication of 5-year outcomes for patients treated unilaterally with Lumevoq gene therapy: Paris, France Thursday, January 16, 2025, 18:00 Hrs [IST] ...
Pharmabiz6d
FPME demands policy reforms to address critical issues hampering export ecosystem
The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) has urged the authorities to address critical issues hampering India's pharmaceutical export ecosystem, highlighting the ...
Pharmabiz6d
AIPPSPA urges Kerala DCA to carry out separate inspections at discount pharmacies to ensure quality of drugs
Expressing concerns over the quality of medicines sold through discount pharmacies in Kerala, the state president of the All India Public and Private Sector Pharmacists Association (AIPPSPA), ...
Pharmabiz5d
NPPA recalculates ceiling price of azithromycin 250 mg following review order
The National Pharmaceutical Pricing Authority (NPPA) has released the revised calculation sheet for the ceiling price of azithromycin 250 mg tablet following a review order from the Department of ...
Pharmabiz5d
CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis
CAGE Bio, Inc., a clinical-stage biotechnology company advancing innovative therapies for high incidence immuno-dermatological disorders, announced the initiation of a phase 2b dose-ranging trial for ...
Pharmabiz5d
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology
Boehringer Ingelheim and Synaffix B.V. (Synaffix), a Lonza company focused on commercializing its clinical-stage platform technology for the development of best-in-class antibody-drug conjugates (ADCs ...
Pharmabiz7d
Parliamentary panel asks PMBI to take steps to ensure quality of drugs sold through JAKs
The Parliamentary panel that reviewed the budget allocation for the Department of Pharmaceuticals (DoP) and related matters has sought the Pharmaceuticals & Medical Devices Bureau of India (PMBI), the ...
Pharmabiz5d
EU looks at India as best option over China, reflecting potential shifts in trade dynamics
The European Union's preference for India over China in the pharmaceutical sector is rooted in several strategic factors including the access to qualified and skilled workforce. India has a proven ...